Anxiolysis with oral midazolam in pediatric patients undergoing dermatologic surgical procedures - 02/09/11
Abstract |
Background: Pediatric patients undergoing dermatologic surgical procedures often experience high levels of anxiety. Oral midazolam is a short-acting benzodiazepine that can ameliorate procedure-related anxiety. Objective: Our purpose was to determine the safety and efficacy of oral midazolam as an adjuvant anxiolytic agent for pediatric patients undergoing dermatologic surgical procedures. Methods: A prospective series of pediatric patients undergoing dermatologic surgical procedures who received oral midazolam were monitored, and efficacy and complications were recorded. Results: Oral midazolam provided good to excellent anxiolytic effects in most pediatric patients undergoing painful dermatologic surgical procedures. Because midazolam does not provide analgesic effects, local anesthesia is necessary. Complications were uncommon and minor. Conclusion: Oral midazolam is an effective anxiolytic agent in pediatric patients undergoing dermatologic surgical procedures. (J Am Acad Dermatol 2001;45:105-8.)
Le texte complet de cet article est disponible en PDF.Plan
Reprint requests: Clark C. Otley, MD, Department of Dermatology, Mayo Clinic, 200 First St SW, Rochester, MN 55905. |
Vol 45 - N° 1
P. 105-108 - juillet 2001 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?